mefloquine has been researched along with Tuberculosis, Drug-Resistant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lie, W; Pyne, SG; Seephonkai, P; Willis, AC | 1 |
| Abbadi, BL; Basso, LA; Campos, MM; de Souza, MV; Gonçalves, RS; González-Martín, J; López-Gavín, A; Rodrigues-Junior, VS; Santos, DS; Trindade, RV; Tudó, G; Villela, AD | 1 |
2 other study(ies) available for mefloquine and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
Bioactive compounds from the roots of Strophioblachia fimbricalyx.
Topics: Antimalarials; Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Euphorbiaceae; Heterocyclic Compounds, 4 or More Rings; Humans; KB Cells; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plant Roots; Plasmodium falciparum; Thailand; Tuberculosis, Multidrug-Resistant | 2013 |
Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection.
Topics: Animals; Antitubercular Agents; Bacterial Load; Disease Models, Animal; Drug Interactions; Drug Repositioning; Male; Mefloquine; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazoles; Tuberculosis, Multidrug-Resistant | 2016 |